Wells Fargo Upgrades Enzymotec (ENZY) to Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Enzymotec (ENZY) Tops Q2 EPS by 5c, Updates FY Guidance
August 12, 2015 7:55 AM EDTEnzymotec (NASDAQ: ENZY) reported Q2 EPS of $0.11, $0.05 better than the analyst estimate of $0.06. Revenue for the quarter came in at $13.4 million versus the consensus estimate of $12.39 million.
Enzymotec sees FY2015 EPS of $0.28-$0.36, versus the consensus of $0.28. Enzymotec sees FY2015 revenue of $53-59... More
